NeoVac is a clinical-stage company creating a revolutionary, unique and proprietary next-generation lipid nanoparticles platform to enable better RNA vaccines and medicines for various diseases. Allowing more people around the world access to better and more potent vaccines, using cutting-edge technology that makes RNA vaccines more transportable, with broader capabilities and fewer side effects.
| Website | http://www.neovac.co.uk |
| Employees | 28 (19 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Lipid Nanoparticles, Rna Vaccines, Vaccine Technology, Nanoparticle Technology, Rna Therapeutics, Rna Delivery, Vaccine Development, Drug Delivery, Next Generation Vaccines, Nanomedicine, Advanced Drug Delivery, Clinical Stage, Pharmaceutical Research, Drug Development, Therapeutic Platform, Innovative Medicines, Biotechnology, Gene Therapy, Novel Therapeutics, Precision Medicine |
| Competitors | ToxServices LLC, Envigo ++++, Eurofins, Veristat, Kingfisher Biotech, MP Biomedicals, SGS, Fisher Scientific, Charles River Media Inc, Altasciences +32 more (view full list) |
Looking for a particular NeoVac employee's phone or email?
NeoVac Questions
Jan Egberts is the CEO of NeoVac.
19 people are employed at NeoVac.
Top NeoVac Employees
-
11
-
31
-
2
-
Ramishetti Srinivas
SVP-Research at NeoVac
United Kingdom32 -
Denis Besic
VP of Analytics at NeoVac
Abingdon, GB31 -
2
-
21
-
Anna Gutkin
Project Manager and Grant Writer at NeoVac
United States3
Related Companies
G2Crowd Trusted
300K+
Plugin Users
